Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00841009 · ClinicalTrials.gov registry record
Effect of Gastric Bypass-induced Weight Loss on Myocardial Structure, Function and Metabolism
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 18
- Enrollment target
NCT00841009: Completed study, sponsored by Washington University School of Medicine.
NCT00841009 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00841009 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Obesity affects more than 43 million Americans and is associated with an increased incidence of heart failure, sudden death, and cardiovascular death. We have shown that increasing obesity is independently associated with potentially detrimental LV structural and functional, and metabolic changes. Thus in order to increase our understanding of the effect of obesity on the heart, we wish to study the effect of significant weight loss on these parameters.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2005-07 |
| Est. Completion | 2014-06 |
What the finished NCT00841009 record still lists
NCT00841009 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00841009 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00841009 about?
NCT00841009 is a clinical study titled "Effect of Gastric Bypass-induced Weight Loss on Myocardial Structure, Function and Metabolism". Obesity affects more than 43 million Americans and is associated with an increased incidence of heart failure, sudden death, and cardiovascular death. We have shown that increasing obesity is independently associated with potentially detrimental LV structural and functional, and metabolic changes. T...
What is the current status of trial NCT00841009?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2005-07. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT00841009?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia